Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis have?
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis has 72 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis published?
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis has 2018 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis?
Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis?
The DOI for Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis is on the source record.
What is the PMID of Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis?
The PMID for Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis is on the source record.
What is the OpenAlex record for Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis?
The OpenAlex for Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis is on the source record.